BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Tibotec 

1020 Stony Hill Road
Suite 300
Yardley  Pennsylvania  19067  U.S.A.
Phone: 609-730-7500 Fax: 609-730-7501


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Medivir AB (MVIRb.F)’s Partner Tibotec Announced that Final SVR24 Results from Phase IIb PILLAR Study of TMC435 will be Presented at the AASLD Meeting Today 11/7/2011 7:30:41 AM
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ)'s Tibotec Unit to Develop Combination HIV Drug 6/28/2011 7:45:38 AM
FDA Approves Tibotec's New HIV Treatment, Edurant 5/20/2011 10:28:49 AM
Tibotec Advances Global Clinical Research Program for TMC435 in HCV; Will Present Four Abstracts Evaluating Safety and Efficacy at EASL 3/29/2011 7:10:22 AM
Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV 2/18/2011 6:35:14 AM
Tibotec: Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 9/21/2010 9:41:05 AM
Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 6/18/2009 8:34:26 AM